We studied the influence of
acidosis on the positive inotropic effect of
UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-
benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of
pimobendan, in canine ventricular trabeculae loaded with
aequorin. The positive inotropic effect of
UD-CG 212 Cl was markedly suppressed under acidotic conditions. The maximal contractile response to
UD-CG 212 Cl was attained
at 10(-5) M in the control condition at pH 7.4, but was not achieved even
at 10(-4) M during
acidosis. The maximal inotropic effect of
UD-CG 212 Cl was 18% of the maximal response to
isoproterenol (ISO(max)) in association with an increase in Ca(2+) transients of 7% of ISO(max) in the control, while they are 8 and 6% of ISO(max) under
acidosis, respectively.
Acidosis abolished the increase in myofilament Ca(2+) sensitivity induced by
UD-CG 212 Cl, whereas the increase in Ca(2+) transients induced by the compound was not affected by
acidosis. In conclusion,
UD-CG 212 Cl elicited a positive inotropic effect even under
acidosis, however,
UD-CG 212 Cl was much less effective as a
cardiotonic agent under
acidosis mainly due to a decrease in the Ca(2+)-sensitizing effect under acidotic condition.